Organization
The Fifth Affiliated Hospital of Sun Yat-sen University
2 abstracts
Abstract
Neoadjuvant low-dose radiotherapy, tislelizumab, combined with albumin-bound paclitaxel and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoRTPC02): The first-stage result from an open label, single-arm, two stage, phase II clinical trial.Org: The Cancer Center of Affiliated Dongguan Hospital of Southern Medical University, Cancer Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China, The Fifth Affiliated Hospital of Sun Yat-sen University, Dongguan Key Laboratory of Precision Diagnosis and Treatment for Tumors, Affiliated Dongguan Hospital of Southern Medical University,
Abstract
A phase II study cohort of penpulimab plus anlotinib in patients with recurrent or metastatic non-squamous cell carcinomas of head and neck.Org: National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Peking University Cancer Hospital and Institute (Beijing Cancer Hospital), Beijing, China, Gansu Provincial Cancer Hospital,